These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8043303)

  • 1. Increased calcium absorption in nephrolithiasis explained by uptake studies in ileal brush border membrane vesicles.
    Ioannoni B; Chalmers AH
    Biochem Med Metab Biol; 1994 Apr; 51(2):99-104. PubMed ID: 8043303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical factors important to calcium nephrolithiasis: evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1987 Feb; 33(2 Pt 1):243-7. PubMed ID: 3802507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of citrate on the urinary excretion of calcium and oxalate: relevance to calcium oxalate nephrolithiasis.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1989 Jan; 35(1):23-8. PubMed ID: 2910576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effect of cadmium on citrate uptake by isolated rat renal brush border membrane vesicles.
    Sato K; Kusaka Y; Okada K
    Toxicol Lett; 1995 Oct; 80(1-3):161-5. PubMed ID: 7482584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. URINARY EXCRETION OF CALCIUM AND CITRATE IN NORMAL INDIVIDUALS AND STONE FORMERS WITH VARIATION IN CALCIUM INTAKE.
    MCINTOSH HW; SERAGLIA M
    Can Med Assoc J; 1963 Dec; 89(24):1242-3. PubMed ID: 14084708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of calcium and calmodulin in the regulation of the rabbit ileal brush-border membrane Na+/H+ antiporter.
    Emmer E; Rood RP; Wesolek JH; Cohen ME; Braithwaite RS; Sharp GW; Murer H; Donowitz M
    J Membr Biol; 1989 Jun; 108(3):207-15. PubMed ID: 2550651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro effect of citrate and phosphates on calcium transport in the rat ileum].
    Lacour B; Ohan J; Nabarra B; Drueke T
    Gastroenterol Clin Biol; 1994; 18(11):938-44. PubMed ID: 7705581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects.
    Lindsjö M; Danielson BG; Fellström B; Ljunghall S
    Scand J Urol Nephrol; 1989; 23(1):55-9. PubMed ID: 2922580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.
    Trinchieri A; Lizzano R; Castelnuovo C; Zanetti G; Pisani E
    Arch Ital Urol Androl; 2002 Jun; 74(2):61-4. PubMed ID: 12161938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocitraturia in calcium nephrolithiasis.
    Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleic acid uptake by jejunal and ileal rat brush border membrane vesicles.
    Prieto RM; Stremmel W; Sales C; Tur JA
    Eur J Med Res; 1996 Jan; 1(4):199-203. PubMed ID: 9386269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acid uptake and calcium flux in brush border membrane vesicles.
    Fondacaro JD; Garvey JL
    Life Sci; 1983 Mar; 32(13):1449-54. PubMed ID: 6834998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
    Preminger GM; Sakhaee K; Skurla C; Pak CY
    J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrate and renal calculi: an update.
    Pak CY
    Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malic acid supplementation increases urinary citrate excretion and urinary pH: implications for the potential treatment of calcium oxalate stone disease.
    Rodgers AL; Webber D; de Charmoy R; Jackson GE; Ravenscroft N
    J Endourol; 2014 Feb; 28(2):229-36. PubMed ID: 24059642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin-mediated effects of loperamide on chloride transport by brush border membrane vesicles from human ileum.
    Stoll R; Ruppin H; Domschke W
    Gastroenterology; 1988 Jul; 95(1):69-76. PubMed ID: 2836258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.